chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Palpitations, Tenderness, Throat tightness, Troponin increased
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Catheterisation cardiac, Chest pain, Laboratory test
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.
Age: 49.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Lymphadenopathy, Oedema peripheral, Pain in extremity, Paraesthesia
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 454102. A 49-year-old female patient received the following vaccination on 21 January 2012: ACAM2000 (lot number VV04003A). Three days post inoculation the patient had swollen lymph nodes in the right arm as well as pain and swelling in the right arm. She also had tingling in the fingers in the right hand. Laboratory data were not reported. Medical history and current illnesses were reported as "None." The patient had not recovered. Documents held by sender: None.
Age: 43.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Computerised tomogram head normal, VIIth nerve paralysis
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 454176. A 43-year-old male patient received the following vaccination on 05 April 2012: ACAM2000 (lot number VV04003A). Fifteen days post inoculation the patient began with right facial paralysis. Three days later he went to the ER (emergency room) and was diagnosed with Bell's Palsy. Cat Scan (CT) of the brain was negative. The patient was released on prednisone and VALTREX. Recovery status was not reported. Documents held by sender: None.
Age: 43.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Computerised tomogram head, Computerised tomogram normal, VIIth nerve paralysis
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 454176. A 43-year-old male patient received the following vaccination on 05 April 2012: ACAM2000 (lot number VV04003A). Fifteen days post inoculation the patient began with right facial paralysis. Three days later he went to the ER (emergency room) and was diagnosed with Bell's Palsy. Cat Scan (CT) of the brain was negative. The patient was released on prednisone and VALTREX. Recovery status was not reported. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Post vaccination autoinoculation, Scab
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 454256. A 23-year-old male patient received the following vaccination on 04 April 2012: ACAM2000 (lot number VV04003A). Sixteen days post inoculation there was appearance of round crusted lesion consistent with auto-inoculation at distant site. No laboratory testing was performed. History was reported as "None" and there were no current illnesses. The patient recovered. Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Post vaccination autoinoculation, Scab, Skin lesion
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 454256. A 23-year-old male patient received the following vaccination on 04 April 2012: ACAM2000 (lot number VV04003A). Sixteen days post inoculation there was appearance of round crusted lesion consistent with auto-inoculation at distant site. No laboratory testing was performed. History was reported as "None" and there were no current illnesses. The patient recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, IPV, SMALL, TYP, ANTH, IPV, SMALL, TYP
Symptoms: Papule, Rash erythematous, Rash vesicular, Sunburn
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 454757. A 21-year-old male patient received the following vaccinations on 30 March 2012: ACAM2000 (lot number VV840038), IPOL (lot number EA0450), TYPHIM VI (lot number EC442) and BIOTHRAX (lot number EA0304). On 14 April 2012, the patient experienced a vesicular rash with erythematous base that erupted one day after receiving sunburn on face and arms at day 16 post smallpox vaccination. The rash was mainly on both elbows and forearms with vesicles coalescing and erythematous papules on forearms, hands and few on legs. The patient had no past medical history and took no concomitant medications. The patient's outcome was recovered. Documents held by sender: None.
Age: 60.0
Sex: F
Vaccine: FLUX, OPV, SMALL, TD, FLUX, OPV, SMALL, TD
Symptoms: Generalised erythema, Pyrexia, Sluggishness, Throat irritation
Clinical narrative: This case was received on 06 August 2012 via a third party query tool search on the VAERS database, under reference number 455243. A 60-year-old female patient received the following vaccinations on 05 May 2012: a first dose left arm administration of ACAM2000, a first dose left arm administration of seasonal Influenza vaccine (manufacturer unknown), a dose of Tetanus Diphtheria vaccine (manufacturer unknown) and an oral dose of OPV (other manufacturer); the unspecified lot numbers, routes and sites of administration were not reported. On 07 May 2012 (also reported as "on Monday"), two days after receiving the vaccines, the patient started with a scratchy throat and felt sluggish all day. By Tuesday morning she was running a fever and her body was reddish. Concomitant medications consisted of PREMARIN, generic ZOLOFT, Meloxicam, IMODIUM and Sucralfate. She had no known current illness and she had a past history of IBS. Outcome was recovered. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Activities of daily living impaired, Chest X-ray, Chest pain, Dyspnoea, Electrocardiogram ST segment normal
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455471. A 25-year-old male patient received the following vaccination on 06 March 2012: ACAM2000 (lot number not reported). Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 15 March 2012, the patient started having chest pain and shortness of breath (SOB). He could not exercise or run. The patient never had this problem with running or exercise, had no cardiac history and was essentially healthy. The patient went to the emergency department (ED) and had a normal chest x-ray and EKG. At the ED, he denied SOB and reported dull constant left sided chest pain that worsened with exertion. The patient left the ED before the work-up was completed, was working and was pain free. The patient had no current illness and no past medical history. The patient took no concomitant medications. The patient's outcome was recovered. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram normal
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455471. A 25-year-old male patient received the following vaccination on 06 March 2012: ACAM2000 (lot number not reported). Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 15 March 2012, the patient started having chest pain and shortness of breath (SOB). He could not exercise or run. The patient never had this problem with running or exercise, had no cardiac history and was essentially healthy. The patient went to the emergency department (ED) and had a normal chest x-ray and EKG. At the ED, he denied SOB and reported dull constant left sided chest pain that worsened with exertion. The patient left the ED before the work-up was completed, was working and was pain free. The patient had no current illness and no past medical history. The patient took no concomitant medications. The patient's outcome was recovered. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Activities of daily living impaired, Chest X-ray normal, Chest pain, Dyspnoea, Electrocardiogram normal
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455471. A 25-year-old male patient received the following vaccination on 06 March 2012: ACAM2000 (lot number not reported). Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 15 March 2012, the patient started having chest pain and shortness of breath (SOB). He could not exercise or run. The patient never had this problem with running or exercise, had no cardiac history and was essentially healthy. The patient went to the emergency department (ED) and had a normal chest x-ray and EKG. At the ED, he denied SOB and reported dull constant left sided chest pain that worsened with exertion. The patient left the ED before the work-up was completed, was working and was pain free. The patient had no current illness and no past medical history. The patient took no concomitant medications. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dyskinesia, Musculoskeletal stiffness, Tenderness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455647. A 19-year-old male patient received the following vaccinations on 08 May 2012: ACAM2000 (SP Biologics Co., lot number VV04003A) (site unknown); TYPHIM Vi (sanofi pasteur SA, lot number G1124, intramuscular (site unknown); and BIOTHRAX (EMERGENT, lot number FAV305 (route and site unknown). (There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the date reported. Latency has been calculated using the event date). On 09 May 2012, the patient reported that within 24 hours post immunization on 08 May 2012 (event onset date reported as 09 May 2012) he was unable to open his mouth. He had no history of injury or prior history and had normal (NML) occlusion. Per "PCM", the patient was unable to open mouth more than a few millimeters (mm). The patient denied fever, pain, or cramping. The patient reported stiffness of muscles about "(R)" angle of mandible with some associated tenderness. Treatments included cyclobenzaprine and methocarbamol. The patient was seen in follow-up on 10 May 2012 and reported after taking the prescribed medications; he was able to open his mouth normally without pain of spasm since 2400 hours previous night. Currently, he has been feeling well without having jaw spasms and was able to communicate clearly and normally. The patient required an emergency room visit. The patient was reported as recovered. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Dyskinesia, Musculoskeletal stiffness, Myalgia, Trismus
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455647. A 19-year-old male patient received the following vaccinations on 08 May 2012: ACAM2000 (SP Biologics Co., lot number VV04003A) (site unknown); TYPHIM Vi (sanofi pasteur SA, lot number G1124, intramuscular (site unknown); and BIOTHRAX (EMERGENT, lot number FAV305 (route and site unknown). (There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the date reported. Latency has been calculated using the event date). On 09 May 2012, the patient reported that within 24 hours post immunization on 08 May 2012 (event onset date reported as 09 May 2012) he was unable to open his mouth. He had no history of injury or prior history and had normal (NML) occlusion. Per "PCM", the patient was unable to open mouth more than a few millimeters (mm). The patient denied fever, pain, or cramping. The patient reported stiffness of muscles about "(R)" angle of mandible with some associated tenderness. Treatments included cyclobenzaprine and methocarbamol. The patient was seen in follow-up on 10 May 2012 and reported after taking the prescribed medications; he was able to open his mouth normally without pain of spasm since 2400 hours previous night. Currently, he has been feeling well without having jaw spasms and was able to communicate clearly and normally. The patient required an emergency room visit. The patient was reported as recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Petechiae, Platelet count decreased, Platelet morphology abnormal
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455682. A 21-year-old male patient received the following vaccination on 26 April 2012: ACAM2000 (lot number VV004003A) and on 14 May 2012, 18 days after receiving the vaccine, he presented with petechiae and platelet count of 1,000 confirmed by morphology. The patient was clinically stable but required urgent medevac and hospitalization. He had no current illnesses, no other medications and no past history. The event was considered to be life threatening. Outcome was recovered (date not reported). Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: ANTH, HEPA, SMALL, TYP, SMALL, ANTH, HEPA, SMALL, TYP
Symptoms: Axillary pain, Chills, Headache, Lymph node pain, Lymphadenopathy
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455750. A 24-year-old female patient received the following vaccinations on 07 May 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number G11241), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On 12 May 2012, the patient experienced an onset of painful left sided lymphadenopathy, malaise and subjective chills without temperature check. The patient was seen on 16 May 2012 and prescribed MEDROL Dose Pack (DP), VICODIN 5mg and Naproxen 500mg. The patient currently complained of painful left sided neck, axillary and clavicle swelling, moderate throbbing parietal headache (HA) without hearing or vision changes. The patient had no nausea/vomiting/diarrhea (n/v/d) and denied symptoms on the right side of the upper body or lower extremity neuropathy. The patient had tender left sided submandibular, posterior cervical, axillary lymph node swelling without erythema or discharge, 3x6cm oval shaped localized non-blanching erythema around the smallpox vaccination site and the vaccination site appeared consistent with post-injection period with no significant concerning skin changes other than noted. The patient discontinued prednisone and continued Naproxen 500mg twice daily and VICODIN 5mg as needed (PRN) for pain. The patient was to return to the clinic (RTC) in one day for reevaluation. The indurated erythema delineated in marker 0800 that day, the dressing was changed and "T3 profile for 10 days." Past medical history and concomitant medications were not reported. The patient's outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: ANTH, HEPA, SMALL, TYP, SMALL, ANTH, HEPA, SMALL, TYP
Symptoms: Malaise, Neck pain, Swelling
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455750. A 24-year-old female patient received the following vaccinations on 07 May 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number G11241), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On 12 May 2012, the patient experienced an onset of painful left sided lymphadenopathy, malaise and subjective chills without temperature check. The patient was seen on 16 May 2012 and prescribed MEDROL Dose Pack (DP), VICODIN 5mg and Naproxen 500mg. The patient currently complained of painful left sided neck, axillary and clavicle swelling, moderate throbbing parietal headache (HA) without hearing or vision changes. The patient had no nausea/vomiting/diarrhea (n/v/d) and denied symptoms on the right side of the upper body or lower extremity neuropathy. The patient had tender left sided submandibular, posterior cervical, axillary lymph node swelling without erythema or discharge, 3x6cm oval shaped localized non-blanching erythema around the smallpox vaccination site and the vaccination site appeared consistent with post-injection period with no significant concerning skin changes other than noted. The patient discontinued prednisone and continued Naproxen 500mg twice daily and VICODIN 5mg as needed (PRN) for pain. The patient was to return to the clinic (RTC) in one day for reevaluation. The indurated erythema delineated in marker 0800 that day, the dressing was changed and "T3 profile for 10 days." Past medical history and concomitant medications were not reported. The patient's outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: ANTH, HEPA, SMALL, TYP, SMALL, ANTH, HEPA, SMALL, TYP
Symptoms: Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455750. A 24-year-old female patient received the following vaccinations on 07 May 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number G11241), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On 12 May 2012, the patient experienced an onset of painful left sided lymphadenopathy, malaise and subjective chills without temperature check. The patient was seen on 16 May 2012 and prescribed MEDROL Dose Pack (DP), VICODIN 5mg and Naproxen 500mg. The patient currently complained of painful left sided neck, axillary and clavicle swelling, moderate throbbing parietal headache (HA) without hearing or vision changes. The patient had no nausea/vomiting/diarrhea (n/v/d) and denied symptoms on the right side of the upper body or lower extremity neuropathy. The patient had tender left sided submandibular, posterior cervical, axillary lymph node swelling without erythema or discharge, 3x6cm oval shaped localized non-blanching erythema around the smallpox vaccination site and the vaccination site appeared consistent with post-injection period with no significant concerning skin changes other than noted. The patient discontinued prednisone and continued Naproxen 500mg twice daily and VICODIN 5mg as needed (PRN) for pain. The patient was to return to the clinic (RTC) in one day for reevaluation. The indurated erythema delineated in marker 0800 that day, the dressing was changed and "T3 profile for 10 days." Past medical history and concomitant medications were not reported. The patient's outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: ANTH, HEPA, SMALL, TYP, SMALL, ANTH, HEPA, SMALL, TYP
Symptoms: Chills, Headache, Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455750. A 24-year-old female patient received the following vaccinations on 07 May 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number G11241), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On 12 May 2012, the patient experienced an onset of painful left sided lymphadenopathy, malaise and subjective chills without temperature check. The patient was seen on 16 May 2012 and prescribed MEDROL Dose Pack (DP), VICODIN 5mg and Naproxen 500mg. The patient currently complained of painful left sided neck, axillary and clavicle swelling, moderate throbbing parietal headache (HA) without hearing or vision changes. The patient had no nausea/vomiting/diarrhea (n/v/d) and denied symptoms on the right side of the upper body or lower extremity neuropathy. The patient had tender left sided submandibular, posterior cervical, axillary lymph node swelling without erythema or discharge, 3x6cm oval shaped localized non-blanching erythema around the smallpox vaccination site and the vaccination site appeared consistent with post-injection period with no significant concerning skin changes other than noted. The patient discontinued prednisone and continued Naproxen 500mg twice daily and VICODIN 5mg as needed (PRN) for pain. The patient was to return to the clinic (RTC) in one day for reevaluation. The indurated erythema delineated in marker 0800 that day, the dressing was changed and "T3 profile for 10 days." Past medical history and concomitant medications were not reported. The patient's outcome was not reported. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: ANTH, HEPA, SMALL, TYP, SMALL, ANTH, HEPA, SMALL, TYP
Symptoms: Neck pain, Swelling, Tenderness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455750. A 24-year-old female patient received the following vaccinations on 07 May 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number G11241), HAVRIX (lot number AHAVB443AB) and BIOTHRAX (lot number FAV305). On 12 May 2012, the patient experienced an onset of painful left sided lymphadenopathy, malaise and subjective chills without temperature check. The patient was seen on 16 May 2012 and prescribed MEDROL Dose Pack (DP), VICODIN 5mg and Naproxen 500mg. The patient currently complained of painful left sided neck, axillary and clavicle swelling, moderate throbbing parietal headache (HA) without hearing or vision changes. The patient had no nausea/vomiting/diarrhea (n/v/d) and denied symptoms on the right side of the upper body or lower extremity neuropathy. The patient had tender left sided submandibular, posterior cervical, axillary lymph node swelling without erythema or discharge, 3x6cm oval shaped localized non-blanching erythema around the smallpox vaccination site and the vaccination site appeared consistent with post-injection period with no significant concerning skin changes other than noted. The patient discontinued prednisone and continued Naproxen 500mg twice daily and VICODIN 5mg as needed (PRN) for pain. The patient was to return to the clinic (RTC) in one day for reevaluation. The indurated erythema delineated in marker 0800 that day, the dressing was changed and "T3 profile for 10 days." Past medical history and concomitant medications were not reported. The patient's outcome was not reported. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Meningitis aseptic, Vaccination complication
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455834. A 20-year-old male patient with history reported as "none", had received the following vaccination on 06 May 2012: ACAM2000 (lot number VV04003A). On 17 May 2012, eleven days after receiving the vaccine, the patient was diagnosed with aseptic meningitis due to smallpox vaccination. Laboratory data was unknown and had been performed at a facility. Current illnesses was reported as "no", however the patient had been taking Amoxicillin at the time of vaccination. Recovery was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Laboratory test, Meningitis aseptic
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455834. A 20-year-old male patient with history reported as "none", had received the following vaccination on 06 May 2012: ACAM2000 (lot number VV04003A). On 17 May 2012, eleven days after receiving the vaccine, the patient was diagnosed with aseptic meningitis due to smallpox vaccination. Laboratory data was unknown and had been performed at a facility. Current illnesses was reported as "no", however the patient had been taking Amoxicillin at the time of vaccination. Recovery was reported as unknown. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Lymph node pain, Lymphadenectomy, Lymphadenopathy
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455837. A 24 year-old female patient had received on 07 May 2012 a left arm injection of ACAM2000 (lot number VV04003A) and nine days later on 16 May 2012, experienced swollen tender lymphadenopathy in axilla; "confirmed major reaction". The patient was treated with anti-inflammatory. Lymphadenectomy was coded but not mentioned in the case narrative. According to the report, the patient was to continue to follow-up daily until resolved and "to determine course of treatment". Other medications were reported as OCP. Lab data, current illnesses and history was reported as none. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Age: 18.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema multiforme, Pruritus, Rash papular
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455854. An 18 year-old female patient had received on 26 April 2012 a left arm injection of ACAM2000 (lot number VV04003A) and 19 days later on 15 May 2012, presented with nonspecific diffuse papular rash with secondary pruritus; no mucosal involvement. According to the report, targetoid lesions appeared within 24 hours. The patient had an emergency visit and was treated with PREDNISONE. The "likely diagnosis was erythema multiforme". Other medications, Lab data, current illnesses and history were reported as none. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Exposure to vaccinated person, Infection transmission via personal contact, Polymerase chain reaction, Vaccinia test positive
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455885. On 20 April 2012, a 19-year-old male patient came in contact with the smallpox vaccination site of another vaccinee, (who received ACAM2000, lot number VV04003A (site unknown) on 16 April 2012). The vaccinee was allowing his smallpox vaccination site to "air dry" with no bandage on the site while in his work station. The patient came from behind the vaccinee and tried to wrestle him. The patient's forearm came in contact with the vaccinee's smallpox vaccination site. Two days later, on 22 April 2012, the patient noted a small white lesion on his right forearm. The patient had an (also reported as emergency visit) medical evaluation on 04 May 2012. The provider determined the patient (pt) most likely had a contact transmission and the health center (HC) was notified. The patient had no contraindications to receipt of the smallpox vaccine. On 14 May 2012, a specimen was collected for polymerase chain reaction (PCR), which test positive for vaccinia on same date, 14 May 2012. The patient had a history of G6PD deficiency and prior vaccinations (unspecified); no current illnesses or concomitant medications. No treatments were reported. The patient's outcome was reported as recovered (date not specified). Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Polymerase chain reaction, Secondary transmission, Skin lesion, Vaccinia test positive
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455885. On 20 April 2012, a 19-year-old male patient came in contact with the smallpox vaccination site of another vaccinee, (who received ACAM2000, lot number VV04003A (site unknown) on 16 April 2012). The vaccinee was allowing his smallpox vaccination site to "air dry" with no bandage on the site while in his work station. The patient came from behind the vaccinee and tried to wrestle him. The patient's forearm came in contact with the vaccinee's smallpox vaccination site. Two days later, on 22 April 2012, the patient noted a small white lesion on his right forearm. The patient had an (also reported as emergency visit) medical evaluation on 04 May 2012. The provider determined the patient (pt) most likely had a contact transmission and the health center (HC) was notified. The patient had no contraindications to receipt of the smallpox vaccine. On 14 May 2012, a specimen was collected for polymerase chain reaction (PCR), which test positive for vaccinia on same date, 14 May 2012. The patient had a history of G6PD deficiency and prior vaccinations (unspecified); no current illnesses or concomitant medications. No treatments were reported. The patient's outcome was reported as recovered (date not specified). Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: TDAP, SMALL
Symptoms: Erythema, Injection site induration, Injection site warmth, Mobility decreased, Muscle tightness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455987. A 46-year-old female patient received the following vaccination on 09 May 2012: ACAM2000 (lot number U4325AA). On the same day after the vaccination, the site was hard and warm to the touch. The patient did not have a fever. The skin was tight, muscle was tight and it was hard to raise the arm. No treatment was provided just observation. Twelve days later, the patient was starting to feel better, the redness was gone and the warmth feeling was gone. The arm was still slightly tender when raising her arm above her head and not so much to the touch. The patient had no past medical history. Concomitant medications included cyclobenzaprine, NORCO, VICODIN ES, ibuprofen, melatonin, NECON 1-35-28 and trazodone. The patient was seen at the time for a routine health screening visit. The patient's outcome was recovered. Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: TDAP, SMALL
Symptoms: Skin tightness, Tenderness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455987. A 46-year-old female patient received the following vaccination on 09 May 2012: ACAM2000 (lot number U4325AA). On the same day after the vaccination, the site was hard and warm to the touch. The patient did not have a fever. The skin was tight, muscle was tight and it was hard to raise the arm. No treatment was provided just observation. Twelve days later, the patient was starting to feel better, the redness was gone and the warmth feeling was gone. The arm was still slightly tender when raising her arm above her head and not so much to the touch. The patient had no past medical history. Concomitant medications included cyclobenzaprine, NORCO, VICODIN ES, ibuprofen, melatonin, NECON 1-35-28 and trazodone. The patient was seen at the time for a routine health screening visit. The patient's outcome was recovered. Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: TDAP, SMALL
Symptoms: Erythema, Injection site induration, Injection site warmth, Mobility decreased, Skin tightness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455987. A 46-year-old female patient received the following vaccination on 09 May 2012: ACAM2000 (lot number U4325AA). On the same day after the vaccination, the site was hard and warm to the touch. The patient did not have a fever. The skin was tight, muscle was tight and it was hard to raise the arm. No treatment was provided just observation. Twelve days later, the patient was starting to feel better, the redness was gone and the warmth feeling was gone. The arm was still slightly tender when raising her arm above her head and not so much to the touch. The patient had no past medical history. Concomitant medications included cyclobenzaprine, NORCO, VICODIN ES, ibuprofen, melatonin, NECON 1-35-28 and trazodone. The patient was seen at the time for a routine health screening visit. The patient's outcome was recovered. Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: TDAP, SMALL
Symptoms: Tenderness
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 455987. A 46-year-old female patient received the following vaccination on 09 May 2012: ACAM2000 (lot number U4325AA). On the same day after the vaccination, the site was hard and warm to the touch. The patient did not have a fever. The skin was tight, muscle was tight and it was hard to raise the arm. No treatment was provided just observation. Twelve days later, the patient was starting to feel better, the redness was gone and the warmth feeling was gone. The arm was still slightly tender when raising her arm above her head and not so much to the touch. The patient had no past medical history. Concomitant medications included cyclobenzaprine, NORCO, VICODIN ES, ibuprofen, melatonin, NECON 1-35-28 and trazodone. The patient was seen at the time for a routine health screening visit. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Adverse reaction, Injection site reaction, Skin lesion
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 456175. A 19-year-old female patient received the following vaccination on 16 May 2012: ACAM2000 (lot number VV04003A) and had a robust reaction on 25 May 2012. Original vaccination site measured at 2x2 and satellite lesions at 3mmx3mm. The patient's vital signs were taken and normal. The patient also placed cayenne pepper on the smallpox site as a home remedy. The patient was being monitored. The patient had no past medical history and took MOTRIN as a concomitant medication. The patient's outcome was unknown. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Skin lesion, Vaccination site reaction
Clinical narrative: This case was received on 08 August 2012 via a third party query tool search on the VAERS database, under reference number 456175. A 19-year-old female patient received the following vaccination on 16 May 2012: ACAM2000 (lot number VV04003A) and had a robust reaction on 25 May 2012. Original vaccination site measured at 2x2 and satellite lesions at 3mmx3mm. The patient's vital signs were taken and normal. The patient also placed cayenne pepper on the smallpox site as a home remedy. The patient was being monitored. The patient had no past medical history and took MOTRIN as a concomitant medication. The patient's outcome was unknown. Documents held by sender: None.
Age: 62.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Decreased appetite, Dizziness, Erythema, Fatigue, Headache
Clinical narrative: Initial information received from a healthcare professional on 24 August 2012. A 62-year-old female patient, whose medical history and ongoing illness included none and concomitant drugs included TOPROL XL, SYNTHROID, LEXAPRO and PROTONIX, had received an intradermal dose of FLUZONE intradermal Sanofi Pasteur Inc. (lot number UT4470BA, expiry date 21 March 2013) in left arm on 21 August 2012 on 3:30 PM. On 22 August 2011, 24 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours the patient had malaise, tiredness, dizziness, loss of appetite, headache and rash has spread to elbow (darkened to real purple color). Laboratory details and corrective treatment were not reported. The patient's outcome was recovered on unspecified date. Documents held by sender: None.
Age: 62.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Local swelling, Malaise, Pain, Rash erythematous
Clinical narrative: Initial information received from a healthcare professional on 24 August 2012. A 62-year-old female patient, whose medical history and ongoing illness included none and concomitant drugs included TOPROL XL, SYNTHROID, LEXAPRO and PROTONIX, had received an intradermal dose of FLUZONE intradermal Sanofi Pasteur Inc. (lot number UT4470BA, expiry date 21 March 2013) in left arm on 21 August 2012 on 3:30 PM. On 22 August 2011, 24 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours the patient had malaise, tiredness, dizziness, loss of appetite, headache and rash has spread to elbow (darkened to real purple color). Laboratory details and corrective treatment were not reported. The patient's outcome was recovered on unspecified date. Documents held by sender: None.
Age: 62.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Laboratory test, Malaise, Pain, Rash
Clinical narrative: Initial information received from a healthcare professional on 24 August 2012. A 62-year-old female patient, whose medical history and ongoing illness included none and concomitant drugs included TOPROL XL, SYNTHROID, LEXAPRO and PROTONIX, had received an intradermal dose of FLUZONE intradermal Sanofi Pasteur Inc. (lot number UT4470BA, expiry date 21 March 2013) in left arm on 21 August 2012 on 3:30 PM. On 22 August 2011, 24 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours after vaccination, the patient experienced fiery red circle (4 inch), raised circle and mild pain. After 48 hours the patient had malaise, tiredness, dizziness, loss of appetite, headache and rash has spread to elbow (darkened to real purple color). Laboratory details and corrective treatment were not reported. The patient's outcome was recovered on unspecified date. Documents held by sender: None.
Age: 45.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Hypoaesthesia
Clinical narrative: Initial report received from a non-health care professional on 22 August 2012. A female patient born whose medical history and concomitant medications were not known had received intramuscular dose of FLUZONE (lot number, dose, and dose number not reported) in left arm region on 09 August 2012. It was reported that on 22 August 2012, the patient visited to report that she had numbness and "dead weight" feeling in opposite side of her body. Details of lab investigations and treatments were not reported. At the time of this report, the patient's outcome was unknown. Documents held by sender: None.
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Electrocardiogram normal, Troponin I increased, Troponin increased
Clinical narrative: This study case was received from the investigator on 16 August 2012. A male subject with no reported past medical history was found to have on 03 August 2012 mild, asymptomatic, transient elevated Troponin level of 0.11 ng/ml 9 days after the subject had received on 25 July 2012 the following vaccines: ACAM2000 (lot number, route and site of administration not reported) and an injection of anthrax vaccine (manufacturer name, lot number, route and site of administration not reported). On 07 August 2012, the subject was notified of elevated Troponin level of 0.11 ng/ml, and a repeat Troponin-I level and ECG were performed the same day. Troponin result was reported as less than 0.10 ng/ml, and the ECG was normal. The subject received adequate follow-up from his PCM (Primary Care Manager) and no further workup/treatments were necessary. No further information was available at the time of the report. The subject's outcome was recovered/resolved on 07 August 2012 (4 days after onset). The investigator considered the SAE to be possibly related to the vaccinations and was also considered to be an "other important medical event." This represents a case of potential myopericarditis per the investigator and has subsequently been referred to the ACAM2000 Myopericarditis Adjudication Committee for assessment. Documents held by sender: none.
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Electrocardiogram normal, Troponin increased
Clinical narrative: This study case was received from the investigator on 16 August 2012. A male subject with no reported past medical history was found to have on 03 August 2012 mild, asymptomatic, transient elevated Troponin level of 0.11 ng/ml 9 days after the subject had received on 25 July 2012 the following vaccines: ACAM2000 (lot number, route and site of administration not reported) and an injection of anthrax vaccine (manufacturer name, lot number, route and site of administration not reported). On 07 August 2012, the subject was notified of elevated Troponin level of 0.11 ng/ml, and a repeat Troponin-I level and ECG were performed the same day. Troponin result was reported as less than 0.10 ng/ml, and the ECG was normal. The subject received adequate follow-up from his PCM (Primary Care Manager) and no further workup/treatments were necessary. No further information was available at the time of the report. The subject's outcome was recovered/resolved on 07 August 2012 (4 days after onset). The investigator considered the SAE to be possibly related to the vaccinations and was also considered to be an "other important medical event." This represents a case of potential myopericarditis per the investigator and has subsequently been referred to the ACAM2000 Myopericarditis Adjudication Committee for assessment. Documents held by sender: none.
Age: 48.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Chills, Erythema, Injection site erythema, Oedema peripheral, Pain in extremity
Clinical narrative: This spontaneous report was received from a registered nurse refers to a 48 years old female patient with possible latex allergy (but patient states she could wear latex gloves) and with out pregnant. The patient was vaccinated subcutaneously into right arm with a single dose of 0.5 PNEUMOVAX 23 (Lot # reported as H013847, expiring 14-MAR-2015) on 11-OCT-2012. It was reported that the patient developed cellulitis in her right arm on 13-OCT-2012 after the vaccination of PNEUMOVAX 23. The patient's arm was red, felt hot, and was swollen. The patient stated that the redness extended from under the arm pit to the elbow. The nurse reported that the patient also developed a fever and chills, with the body temperature reaching as high as 102.0 degrees Fahrenheit. The patient was given AUGMENTIN 875 mg taken once per day for treating the AE. The patient was recovered in October 2012. The patient sought medical attention by calling the nurse. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Pyrexia, Skin warm
Clinical narrative: This spontaneous report was received from a registered nurse refers to a 48 years old female patient with possible latex allergy (but patient states she could wear latex gloves) and with out pregnant. The patient was vaccinated subcutaneously into right arm with a single dose of 0.5 PNEUMOVAX 23 (Lot # reported as H013847, expiring 14-MAR-2015) on 11-OCT-2012. It was reported that the patient developed cellulitis in her right arm on 13-OCT-2012 after the vaccination of PNEUMOVAX 23. The patient's arm was red, felt hot, and was swollen. The patient stated that the redness extended from under the arm pit to the elbow. The nurse reported that the patient also developed a fever and chills, with the body temperature reaching as high as 102.0 degrees Fahrenheit. The patient was given AUGMENTIN 875 mg taken once per day for treating the AE. The patient was recovered in October 2012. The patient sought medical attention by calling the nurse. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Body temperature increased, Cellulitis, Chills, Erythema, Oedema peripheral
Clinical narrative: This spontaneous report was received from a registered nurse refers to a 48 years old female patient with possible latex allergy (but patient states she could wear latex gloves) and with out pregnant. The patient was vaccinated subcutaneously into right arm with a single dose of 0.5 PNEUMOVAX 23 (Lot # reported as H013847, expiring 14-MAR-2015) on 11-OCT-2012. It was reported that the patient developed cellulitis in her right arm on 13-OCT-2012 after the vaccination of PNEUMOVAX 23. The patient's arm was red, felt hot, and was swollen. The patient stated that the redness extended from under the arm pit to the elbow. The nurse reported that the patient also developed a fever and chills, with the body temperature reaching as high as 102.0 degrees Fahrenheit. The patient was given AUGMENTIN 875 mg taken once per day for treating the AE. The patient was recovered in October 2012. The patient sought medical attention by calling the nurse. Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Arthralgia, Back pain, Lymphadenitis, Pain
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 37 years old female patient with asthma and allergic to codeine. The patient was vaccinated intramuscularly with, .5 ml PNEUMOVAX23 on 24-OCT-2012 (Lot number H009826, exp 02/2014). Other suspect therapies included FLUZONE with dosage information as (UNK) on 24-OCT-2012 in the other arm at the same time she received the PNEUMOVAX23. Concomitant medications included: CELEBREX. On 25-OCT-2012, the patient told the reporter that her lymph nodes were swollen under the arm in which the injection was given and the pain is radiating from her back to her front side. She also reported that "all of her joints were stiff". No treatment information was reported. The outcome of all of her joints were stiff, lymph nodes swollen under the arm in which the injection was given and pain is radiating from her back to her front side was reported as recovering/resolving. The relatedness for lymph nodes swollen under the arm in which the injection was given, pain is radiating from her back to her front side and all of her joints were stiff is unknown for PNEUMOVAX23. Additional information has been requested.